EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Exploring Preferences and Priorities in Advanced Parkinson’s Disease: A Discrete Choice Experiment

Pablo Arija, Josefa Domingos, Irene A Malaty, Rajesh Pahwa, K Ray Chaudhuri, Angelo Antonini, Hannah Penton, Marieke Heisen, Connie H Yan, Pavnit Kukreja, Elaheh Shirneshan, Inyoung Lee und 3 weitere

Neurology and Therapy · 2026-06 · 15 (3) · 1303-1326

DOI: 10.1007/s40120-026-00920-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology and Therapy, online erschienen am 02.04.2026. Verfasst von Pablo Arija und 14 weiteren Autor:innen. Beteiligte Einrichtung: Patient-Centered Outcomes, OPEN Health, Marten Meesweg 107, 3068 AV, Rotterdam, The Netherlands. pabloarija@openhealthgroup.com. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Treatments for advanced Parkinson's disease (aPD) are differentiated by efficacy, safety, and modality-related characteristics. As the disease progresses and motor fluctuations worsen, many patients require more frequent dosing or consideration of device-aided therapies, including subcutaneous infusions, intestinal gel delivery systems, or deep brain stimulation. Assessing treatment preferences is valuable to ensure people with aPD (PwP) and care partners (CPs) are satisfied with a treatment's impact on both motor function and quality of life, potentially increasing adherence and effectiveness. METHODS: A total of 304 participants (223 PwP, 81 CPs) from the USA, UK, and Germany were included in the study. A discrete choice experiment (DCE) was used to elicit preferences over treatment characteristics. In the DCE, respondents were presented with a series of choice tasks, each consisting of two hypothetical treatments described by varying levels of seven attributes: daily hours of ON time without troublesome dyskinesia (ONwoTD), frequency of early morning OFF time (EMO), risk of mild-to-moderate skin reactions, risk of severe side effects requiring hospitalization, route of administration (ROA), frequency of pill regimen, and frequency of device maintenance. Analyses with a random parameter logit model were used to estimate attribute conditional relative importance (CRI) and explore how people would trade off across attributes. RESULTS: The average PwP age was 65.7 years (SD 8.6), time since diagnosis was 10.0 years (SD 4.4), and self-reported OFF time was 4.0 h/day (SD 2.4). Within the survey design, ROA emerged as the most important attribute (CRI 35.3), followed by hours of ONwoTD (CRI 26.4). All other attributes were of similar importance. Nonsurgical treatments were strongly preferred, with oral pills being the most preferred, followed by infusion device without surgery (subcutaneous infusion). CONCLUSIONS: PwP prioritized efficacy (ONwoTD) and ROA when considering treatment options. Understanding these preferences may enhance informed and meaningful decision-making between healthcare providers and PwP.

Schlagwörter

Stichwörter der Autor:innen

Advanced Parkinson’s diseaseAttribute relative importanceBenefit–risk trade-offsDiscrete choice experimentNeurologyPatient preferencePatient-centered care

Autor:innen und Institutionen

  • Patient-Centered Outcomes, OPEN Health, Marten Meesweg 107, 3068 AV, Rotterdam, The Netherlands. pabloarija@openhealthgroup.com.
  • Parkinson's Europe, Orpington, UK.
  • Egas Moniz School of Health & Science, Almada, Portugal.
  • Department of Neurology, University of Florida, Norman Fixel Institute for Neurological Diseases, Gainesville, FL, USA.
  • University of Kansas Medical Center, Kansas City, KS, USA.
  • Kings College Hospital London, Dubai, UAE.

Förderung

  • AbbVie

Zitieren

APA

Arija, P., Domingos, J., Malaty, I. A., Pahwa, R., Chaudhuri, K. R., Antonini, A., Penton, H., Heisen, M., Yan, C. H., Kukreja, P., Shirneshan, E., Lee, I., Shah, M., Parra, J. C., & Boeri, M. (2026). Exploring Preferences and Priorities in Advanced Parkinson’s Disease: A Discrete Choice Experiment. Neurology and Therapy, 15(3), 1303-1326. https://doi.org/10.1007/s40120-026-00920-4

Vancouver

Arija P, Domingos J, Malaty IA, Pahwa R, Chaudhuri KR, Antonini A, et al. Exploring Preferences and Priorities in Advanced Parkinson’s Disease: A Discrete Choice Experiment. Neurology and Therapy. 2026;15(3):1303-1326. doi:10.1007/s40120-026-00920-4

BibTeX
@article{Arija2026,
  author = {Arija, Pablo and Domingos, Josefa and Malaty, Irene A and Pahwa, Rajesh and Chaudhuri, K Ray and Antonini, Angelo and Penton, Hannah and Heisen, Marieke and Yan, Connie H and Kukreja, Pavnit and Shirneshan, Elaheh and Lee, Inyoung and Shah, Megha and Parra, Juan Carlos and Boeri, Marco},
  title = {Exploring Preferences and Priorities in Advanced Parkinson’s Disease: A Discrete Choice Experiment},
  journal = {Neurology and Therapy},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {1303--1326},
  doi = {10.1007/s40120-026-00920-4}
}
Kostenlos starten →